Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
Intern Emerg Med
.
2021 Jan;16(1):235-236.
doi: 10.1007/s11739-020-02457-2.
Epub 2020 Sep 21.
Authors
Konstantinos Farsalinos
1
2
,
Anastasia Barbouni
3
,
Raymond Niaura
4
Affiliations
1
Department of Pharmacy, University of Patras, Rio, Greece. kfarsalinos@gmail.com.
2
School of Public Health, Department of Public and Community Health, University of West Attica, Athens, Greece. kfarsalinos@gmail.com.
3
School of Public Health, Department of Public and Community Health, University of West Attica, Athens, Greece.
4
Departments of Social and Behavioral Science and Epidemiology, College of Global Public Health, New York University, New York City, USA.
PMID:
32955678
PMCID:
PMC7502804
DOI:
10.1007/s11739-020-02457-2
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
China / epidemiology
Humans
Nicotine*
Prevalence
SARS-CoV-2
Smoking
Substances
Nicotine